| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/30/2008 | CA2263816C Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
| 12/30/2008 | CA2253207C Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy |
| 12/30/2008 | CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 12/30/2008 | CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 12/30/2008 | CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules |
| 12/25/2008 | US20080319036 administering to overweight subject a pharmaceutical composition comprising a sustained release formulation of zonisamide or a pharmaceutically acceptable salt thereof, either alone or in combination with bupropion or other compound that enhances the activity of norepinephrine and/or dopamine via uptake |
| 12/25/2008 | US20080318972 5-ht1a receptor subtype agonist |
| 12/25/2008 | US20080318970 Treatment of Infectious Diseases |
| 12/25/2008 | US20080318961 Drugs comprising chymase inhibitors and ACE inhibitors as effective ingredients |
| 12/25/2008 | US20080318932 Sodium Channel Blocker Compositions and the Use Thereof |
| 12/25/2008 | US20080318891 Antisense oligonucleotides against thymidylate synthase |
| 12/25/2008 | US20080318866 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 12/25/2008 | US20080318846 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 12/25/2008 | US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity |
| 12/25/2008 | US20080317878 Herbal Therapy for the Treatment of Food Allergy |
| 12/25/2008 | US20080317870 Compositions and Mehtods for Treating and Preventing Cancer Using Analogs of Vitamin D |
| 12/25/2008 | US20080317863 Pharmaceutical Compositions Useful in the Transmucosal Administration of Drugs |
| 12/25/2008 | US20080317833 Novel Anti-Inflammatory Androstane Derivatives |
| 12/25/2008 | US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 12/25/2008 | US20080317747 Recombinant anti-cd30 antibodies and uses thereof |
| 12/25/2008 | US20080317735 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 12/25/2008 | US20080317719 Regulating stem cells |
| 12/25/2008 | US20080317715 Anti-bacterial agents |
| 12/25/2008 | US20080317709 Methods for treating head or neck cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 12/25/2008 | US20080317708 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3dione |
| 12/24/2008 | WO2008156853A2 Inhibition of filovirus entry into cells and uses thereof |
| 12/24/2008 | WO2008156833A2 G2a receptor as a therapeutic target |
| 12/24/2008 | WO2008156550A2 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine |
| 12/24/2008 | WO2008156153A1 Preventive/remedy for cancer |
| 12/24/2008 | WO2008155920A1 Drug having effect of promoting hepatocyte growth |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008154898A2 Preparation for the treatment of equine laminitis |
| 12/24/2008 | WO2008100240A3 Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same |
| 12/24/2008 | WO2007123851A3 Method and apparatus for modifying electrical conduction in the heart with profibrotic blood progenitor cells |
| 12/24/2008 | WO2006127798A3 Anti-adhesin based passive immunoprophylactic |
| 12/24/2008 | EP2006300A2 Characterization of a calcium channel family |
| 12/24/2008 | EP2005956A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical |
| 12/24/2008 | EP2005949A1 Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent |
| 12/24/2008 | EP2005944A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 12/24/2008 | EP2004651A2 Novel cyclobutyl compounds as kinase inhibitors |
| 12/24/2008 | EP2004234A2 Combination of organic compounds |
| 12/24/2008 | EP2004220A2 Methods and compositions for vaccination of poultry |
| 12/24/2008 | EP2004204A1 Treatment of neurodegenerative diseases |
| 12/24/2008 | EP2004192A2 Modified macrophage migration inhibitory factor inhibitors |
| 12/24/2008 | EP2004183A1 Mazindol combination in the treatment of attention deficit/hyperactivity |
| 12/24/2008 | EP2004178A1 Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one jak3 kinase inhibitor for treating autoimmune disorders |
| 12/24/2008 | EP2004175A2 Anti-cancer activity augmentation compounds and formulations and methods of use thereof |
| 12/24/2008 | EP2004168A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists |
| 12/24/2008 | EP2004165A2 Synergistic combinations of anticancer agents for treating cancer |
| 12/24/2008 | EP2004163A2 Combinations comprising mtor inhibitors for treating cancer |
| 12/24/2008 | EP2004157A2 Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, as well as combination therapy relating thereto |
| 12/24/2008 | EP1401418B1 Topical treatments using alkanolamines |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | EP1373206B1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 12/24/2008 | EP1368061B1 Fusion cells and cytokine compositions for treatment of disease |
| 12/24/2008 | EP1328291B1 Viruses targeted to hypoxic cells and tissues |
| 12/24/2008 | EP1218511B1 Antimicrobial compositions |
| 12/24/2008 | CN101331134A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 12/24/2008 | CN101330930A Therapeutic agent for heart disease |
| 12/24/2008 | CN101330929A Inhibitor of transplanted islet dysfunction in islet transplantation |
| 12/24/2008 | CN101330903A Abuse resistant transmucosal drug delivery device |
| 12/24/2008 | CN101327326A Vaginally administered anti-dysrhythmic agents for treating pelvic pain and infertility |
| 12/24/2008 | CN101327325A Ophthalmologic irrigation solutions and method |
| 12/24/2008 | CN101327199A Carotenoids as anti-hypertension agents |
| 12/24/2008 | CN101327190A Anti-tumor long-circulating target liposomes for injections |
| 12/24/2008 | CN101327182A Preparation of nano crystal fibre felt of water-insoluble medicament |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |
| 12/24/2008 | CN100445266C MCH antagonists and their use in treatment of obesity |
| 12/24/2008 | CN100444897C Nano complex eye drops containing liposoluble compound drug and its preparing method |
| 12/24/2008 | CN100444896C Chitin nanometer granule for programmable releasing various kinds of medicine, and its prepn. method |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CN100444838C Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 12/24/2008 | CN100444837C Novel herbal chemical composition for treatment of cancer |
| 12/24/2008 | CN100444744C Supplement preparation |
| 12/24/2008 | CA2692039A1 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling |
| 12/24/2008 | CA2691991A1 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors |
| 12/23/2008 | US7468421 Administering andothelins, or antagonist thereof, as drug or cosmetics for hair removal or wool harvesting |
| 12/23/2008 | US7468390 Angiotensin antagonist valsartan and an enkephalinase inhibitor; used to treat cardiovascular disorders |
| 12/23/2008 | US7468388 Using 5-aceylamino-4-azido-4-nitrophenoxycarbonyloyl) -(2-oxo (1,3-dioxolan-4-yl)-5,6-dihydropyran-2-carxylic acid methyl ester; therapy for myxovirus infections; active materials; stability; long time in lungs |
| 12/23/2008 | US7468363 Immunomodulators; side effect reduction; non-Hodgkin's lymphoma, myelogenous leukemia, amyloidosis, and cancer of ovaries, pancreas, kidneys |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | US7468194 Administering liposomes containing povidone iodine for therapy of bacterial infection |
| 12/23/2008 | US7468189 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 12/23/2008 | US7468188 Multi-step therapy for injured muscles |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | CA2602643C Composition for improving blood cholesterol levels |
| 12/23/2008 | CA2424664C Novel non-imidazole compounds |
| 12/23/2008 | CA2419993C Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 12/23/2008 | CA2360676C A method for treating patients with acne by administering a cyclic gmp pde inhibitor |
| 12/23/2008 | CA2324115C A preventive or therapeutic agent for inflammatory bowel disease comprising il-6 antagonist as an active ingredient |
| 12/23/2008 | CA2314817C Synergistic agents for enhancing tissue repair |
| 12/23/2008 | CA2305799C Composition for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 12/23/2008 | CA2285298C Complexes comprising local anesthetic and nucleic acid and method of making and using the same |
| 12/23/2008 | CA2219641C Diagnostic composition |
| 12/23/2008 | CA2175966C Antibacterial oral gel composition for application to dental implant areas |
| 12/18/2008 | WO2008153207A1 Bicycloaniline derivative |
| 12/18/2008 | WO2008153091A1 Screening method |
| 12/18/2008 | WO2008152421A2 Modification of cytokine levels with glucosylamine compounds |
| 12/18/2008 | WO2008152366A1 Improvements in and relating to mammalian reproduction |
| 12/18/2008 | WO2008152065A1 Composition and uses of a retinoid, an anti-irritant compound and benzoyl peroxide, in acne |